Sept 22 (Reuters) – Vertex Pharmaceuticals Incorporated : * VERTEX ANNOUNCES POSITIVE RESULTS FROM PHASE 2B AMPLIFIED STUDY OF INAXAPLIN IN ADDITIONAL POPULATIONS OF PEOPLE WITH APOL1-MEDIATED KIDNEY
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
MOSCOW, Sept 22 (Reuters) - Russian forces struck a cargo vessel in Ukraine's Black Sea…
VIDEO SHOWS: HIGHLIGHTS FROM THE ASIA GAMES WITH CHINA WINNING SETTING A NEW WORLD RECORD…
By Jason Lange WASHINGTON, Sept 22 (Reuters) - Three-quarters of Americans, some 73%, worry that…
BRUSSELS, Sept 22 (Reuters) - Latvia's Prime Minister Andris Kulbergs said on Tuesday that French…
By Jason Lange WASHINGTON, Sept 22 (Reuters) - Three-quarters of Americans, some 73%, worry that…
VIDEO SHOWS: HIGHLIGHTS FROM THE ASIA GAMES WITH CHINA WINNING SETTING A NEW WORLD RECORD…